ECM Therapeutics, Inc. Email Format
Biotechnology ResearchPennsylvania, United States2-10 Employees
ECM Therapeutics, Inc. is a clinical-stage biotechnology company focused on regenerative medicine, developing extracellular matrix–based materials to support the body’s natural healing processes. Its lead wound care product is designed for challenging wounds such as diabetic foot ulcers, venous leg ulcers, and pressure injuries, as well as complex wounds with tunneling or draining characteristics, conforming to wound geometry and remaining in place in wet environments. The company plans to bring this wound care product to market in 2027. Beyond wound care, ECM Therapeutics is advancing additional ECM-based healing technologies, including front-of-eye surface repair, and is conducting an ongoing IDE study for fistula repair. It is based in Warrendale, Pennsylvania, with a small team, and has pursued collaborations such as a partnership with the University of Pittsburgh Vision Institute to advance optic nerve repair.